- Home
- TNC vs CVAC Comparison
TNC vs CVAC Comparison
Compare TNC & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TNC | CVAC |
|---|---|---|
| Founded | 1870 | 2000 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TNC | CVAC |
|---|---|---|
| Price | $73.91 | $4.50 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 3 |
| Target Price | ★ $102.00 | $6.83 |
| AVG Volume (30 Days) | 140.5K | ★ 1.2M |
| Earning Date | 02-17-2026 | 11-24-2025 |
| Dividend Yield | ★ 1.68% | N/A |
| EPS Growth | N/A | ★ 94.02 |
| EPS | ★ 2.91 | 0.94 |
| Revenue | ★ $1,240,800,000.00 | $83,000,117.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.63 | $23.71 |
| P/E Ratio | $25.33 | ★ $4.83 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $67.32 | $2.48 |
| 52 Week High | $90.44 | $5.72 |
Technical Indicators
Market Signals| Indicator | TNC | CVAC |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 41.16 |
| Support Level | $74.67 | $4.26 |
| Resistance Level | $75.87 | $4.36 |
| Average True Range (ATR) | 1.47 | 0.17 |
| MACD | -0.12 | 0.00 |
| Stochastic Oscillator | 15.25 | 41.84 |
Price Performance
Historical ComparisonAbout TNC Tennant Company
Tennant Co is a manufacturer of floor cleaning equipment, wood flooring, and wood products. It operates in four geographic business units including North America; Latin America; Europe, Middle East, Africa; and Asia Pacific. The company offers products and solutions consisting of mechanized cleaning equipment, detergent-free, and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, specialty surface coatings, and business solutions such as financing, rental and leasing programs, and machine-to-machine asset management solutions.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.